Loading clinical trials...
Loading clinical trials...
Prospective Non-randomized Multicenter Study to Assess the Efficacy Response Duration and Toxicity of RFC as First-line Treatment and R as Maintenance Treatment, in Patients Diagnosed of Follicular Non Hodgkin Lymphoma
Conditions
Interventions
Rituximab Fludarabine Cyclophosphamide
Locations
20
Spain
Hospital Infanta Cristina
Badajoz, Badajoz_Extremadura, Spain
Hospital del Mar
Barcelona, Barcelona_ Cataluña, Spain
Instituto Catalán de Oncología (ICO)
Barcelona, Barcelona_Cataluña, Spain
Hospital San Pedro de Alcántara
Cáceres, Cáceres_Extremadura, Spain
Hospital de Puerto Real
Puerto Real, Cádiz_ Andalucía, Spain
Complejo Hospitalario Xeral_Calde
Lugo, Lugo_ Galicia, Spain
Start Date
September 1, 2004
Primary Completion Date
July 1, 2007
Completion Date
July 1, 2008
Last Updated
May 17, 2010
NCT05529069
NCT05442515
NCT03050268
NCT03938987
NCT05425992
NCT06365671
Lead Sponsor
Asociacion Espanola de Hematologia y Hemoterapia
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions